{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:19:26Z","timestamp":1790662766105,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroscience Methods"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1016\/j.jneumeth.2005.02.004","type":"journal-article","created":{"date-parts":[[2005,3,11]],"date-time":"2005-03-11T11:20:28Z","timestamp":1110540028000},"page":"159-164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Novel oral drug administration in an animal model of neuroleptic therapy"],"prefix":"10.1016","volume":"146","author":[{"given":"Sonja B.","family":"Schleimer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham A.R.","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmine M.","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneumeth.2005.02.004_bib1","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3109\/10401230309085669","article-title":"Management of weight gain associated with antipsychotics","volume":"15","author":"Birt","year":"2003","journal-title":"Ann Clin Psychiat"},{"key":"10.1016\/j.jneumeth.2005.02.004_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/026988119701100102","article-title":"Perspectives on the role of serotonergic mechanisms in pharmacology in schizophrenia","volume":"11","author":"Busatto","year":"1997","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.jneumeth.2005.02.004_bib3","first-page":"5","article-title":"Tardive dyskinesia: Pathophysiology and animal models","volume":"61","author":"Casey","year":"2000","journal-title":"J Clin Psychiat"},{"key":"10.1016\/j.jneumeth.2005.02.004_bib4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0091-3057(93)90079-9","article-title":"Effects of atypical agents on social behaviour in rodents","volume":"45","author":"Corbett","year":"1993","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.jneumeth.2005.02.004_bib5","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0940-2993(99)80139-0","article-title":"A toxicity study of simultaneous administration of Tamoxifen and Diazepam to female Wistar rats","volume":"51","author":"D\u2019Mello","year":"1999","journal-title":"Exp Toxicol Pathol"},{"key":"10.1016\/j.jneumeth.2005.02.004_bib6","first-page":"151","article-title":"How good is social interaction as a test of anxiety?","volume":"vol. 1","author":"File","year":"1988"},{"key":"10.1016\/j.jneumeth.2005.02.004_bib7","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0028-3908(01)00167-8","article-title":"Changes in GABA(A) receptor gene expression induced by withdrawal of, but not by long-term exposure to, zaleplon or zolpidem","volume":"42","author":"Follesa","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jneumeth.2005.02.004_bib8","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF01271298","article-title":"The dose\u2013response characteristics of rat oral dyskinesias with chronic haloperidol or clozapine administration","volume":"104","author":"Gao","year":"1997","journal-title":"J Neural Transmission"},{"key":"10.1016\/j.jneumeth.2005.02.004_bib9","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/ddr.430040209","article-title":"A social interaction model of anxiety sensitive to acutely administered benzodiazepines","volume":"4","author":"Gardener","year":"1984","journal-title":"Drug Develop Res"},{"key":"10.1016\/j.jneumeth.2005.02.004_bib10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.lfs.2003.06.030","article-title":"Behavioral and biochemical studies on chronic mild stress models in rats treated with a Chinese traditional prescription Banxia-houpu decoction","volume":"74","author":"Li","year":"2003","journal-title":"Life Sci"},{"key":"10.1016\/j.jneumeth.2005.02.004_bib11","first-page":"1","article-title":"Chronic treatments with haloperidol and clozapine alter the level of NMDA-R1 mRNA in the rat brain: an in situ hybridization study","volume":"54","author":"Ossowska","year":"2002","journal-title":"Pol J Pharmacol"},{"key":"10.1016\/j.jneumeth.2005.02.004_bib12","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00213-003-1544-5","article-title":"Haloperidol and clozapine antagonise amphetamine-induced disruption of latent inhibition of conditioned taste aversion","volume":"170","author":"Russig","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jneumeth.2005.02.004_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.1988.tb38591.x","article-title":"The development of grooming and its expression in adult animals","volume":"525","author":"Sachs","year":"1988","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.jneumeth.2005.02.004_bib14","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0165-0270(94)00173-E","article-title":"Automation of the social interaction test by a video-tracking system: behavioural effects of repeated phencyclidine treatment","volume":"59","author":"Samms-Dodd","year":"1995","journal-title":"J Neurosci Meth"},{"key":"10.1016\/j.jneumeth.2005.02.004_bib15","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000026566","article-title":"Chronic oral haloperidol and clozapine in rats: A behavioral evaluation","volume":"39","author":"Schmitt","year":"1999","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.jneumeth.2005.02.004_bib16","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0014-2999(94)90722-6","article-title":"Chronic haloperidol, but not clozapine, produces altered oral movements and increased extracellular glutamate in rats","volume":"263","author":"See","year":"1994","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jneumeth.2005.02.004_bib17","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/0091-3057(86)90026-2","article-title":"Effects of neuroleptic drugs on the inhibition of exploratory behaviour induced by a low dose of apomorphine: Implications for the identity of dopamine receptors","volume":"25","author":"Stahle","year":"1986","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.jneumeth.2005.02.004_bib18","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0014-2999(00)00277-6","article-title":"Intravenous and oral clozapine pharmacokinetics, pharmacodynamics, and concentration\u2013effect relations: Acute tolerance","volume":"398","author":"Sun","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jneumeth.2005.02.004_bib19","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0149-7634(02)00008-8","article-title":"The vacuous chewing movement (VCM) model of tardive dyskinesia revisited: is there a relationship to dopamine D(2) receptor occupancy?","volume":"26","author":"Turrone","year":"2002","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.jneumeth.2005.02.004_bib20","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/00004714-199906000-00004","article-title":"Critical review of GABA-ergic drugs in the treatment of schizophrenia","volume":"19","author":"Wassef","year":"1999","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.jneumeth.2005.02.004_bib21","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/00004714-200006000-00011","article-title":"Randomised, placebo-controlled pilot study of Divalproex sodium in the treatment of acute exacerbations of chronic schizophrenia","volume":"20","author":"Wassef","year":"2000","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.jneumeth.2005.02.004_bib22","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00008877-200305000-00005","article-title":"A comparison of drug effects in latent inhibition and the forced swim test differentiates between the typical antipsychotic haloperidol, the atypical antipsychotics clozapine and olanzapine, and the antidepressants imipramine and paroxetine","volume":"14","author":"Weiner","year":"2003","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.jneumeth.2005.02.004_bib23","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s002130050456","article-title":"Validity, reliability and utility of chronic mild stress models of depression: a 10-year review and evaluation","volume":"134","author":"Willner","year":"1997","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jneumeth.2005.02.004_bib24","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1176\/ajp.148.6.714","article-title":"Benzodiazepines in the treatment of schizophrenia: A review and reappraisal","volume":"148","author":"Wolkowitz","year":"1991","journal-title":"Am J Psychiat"},{"key":"10.1016\/j.jneumeth.2005.02.004_bib25","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0301-0082(00)00018-6","article-title":"Elucidation of the neurobiology of depression: insights from a novel genetic animal model","volume":"62","author":"Yadid","year":"2000","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.jneumeth.2005.02.004_bib26","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s00213-003-1460-8","article-title":"Latent inhibition in 35-day-old rats is not an \u201cadult\u201d latent inhibition: Implications for neurodevelopment models of schizophrenia","volume":"169","author":"Zuckerman","year":"2003","journal-title":"Psychopharmacology"}],"container-title":["Journal of Neuroscience Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165027005000580?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165027005000580?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T00:07:18Z","timestamp":1759018038000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165027005000580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["S0165027005000580"],"URL":"https:\/\/doi.org\/10.1016\/j.jneumeth.2005.02.004","relation":{},"ISSN":["0165-0270"],"issn-type":[{"value":"0165-0270","type":"print"}],"subject":[],"published":{"date-parts":[[2005,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel oral drug administration in an animal model of neuroleptic therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroscience Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneumeth.2005.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}